# BPC-157 + TB-500 Blend 10mg

> Source: https://www.auspeptidewarehouse.com.au/products/bpc-157-tb-500-blend
> SKU: APW-BLEND
> Category: Tissue Repair Research
> Last verified: 2026-06-25
> License: RSL-1.0 | AI-Usage: cite-with-attribution

## Quick Facts

| Attribute | Value |
|---|---|
| Product | BPC-157 + TB-500 Blend |
| Specification | 10mg · Lyophilised |
| Purity (HPLC) | 99.0% |
| Price (AUD) | $109.99 |
| Availability | PreOrder (dispatch 7–10 business days) |
| Manufactured | GMP-certified facility |
| Tested by | Janoshik Analytical (independent third-party) |
| Ships from | Melbourne, Australia |

## Description

Research-grade BPC-157 + TB-500 synergistic healing blend 10mg lyophilised powder. 99.0% HPLC purity, COA verified. Combined tissue repair and anti-inflammatory research formula.

## Detailed Overview

**Dual-Pathway Tissue Repair Research**

BPC-157 + TB-500 Blend is available in Australia from Peptide Warehouse Australia with fast domestic shipping to all states and territories.

This blend combines two of the most researched tissue-repair peptides in a single convenient vial. BPC-157 is studied in gastrointestinal, tissue-repair, and anti-inflammatory models. TB-500 is studied for cell migration and angiogenesis in injured-tissue models. Because they act through entirely different biological pathways, researchers often combine them for broader coverage of tissue-repair pathways in preclinical models than either peptide provides alone. Each vial contains 5mg of BPC-157 and 5mg of TB-500, pre-blended and co-lyophilised for easy reconstitution.

**What the BPC-157 + TB-500 Blend Is Studied For**

**Tissue-repair research** — Both peptides independently studied in soft tissue injury models; together they cover complementary repair pathways.
**Gastrointestinal research** — BPC-157's gut-related effects are studied in gut mucosal integrity, inflammation, and mucosal biology models.
**Angiogenesis research** — TB-500 is studied for new blood vessel formation in injured-tissue models, examined for nutrient and oxygen delivery dynamics.
**Anti-inflammatory activity** — Both compounds have been studied for reducing inflammatory markers in acute and chronic injury models.

⚠ For in-vitro laboratory research use only. Not approved for human or veterinary use. Not drugs, food supplements, or cosmetics. Not evaluated or approved by the TGA. You must be 18 years of age or older to purchase. By placing this order, you confirm you are a qualified researcher and will use this compound strictly in accordance with all applicable Australian laws and regulations.

## Research Applications

- 99.0% HPLC purity — combined blend
- 5mg BPC-157 + 5mg TB-500 per vial
- Synergistic research combination
- Full COA for both components
- GMP-certified sourcing

## Shipping

- Standard Post: $8.99 AUD (2–6 business days)
- Express Post: $13.99 AUD (1–3 business days)
- Free shipping on orders over $199 AUD
- Orders placed before 12PM AEST dispatch the same business day; orders after 12PM AEST dispatch the next business day
- Discreet plain packaging, Australia Post tracking on every order

## Frequently Asked Questions

### What is in the BPC-157 + TB-500 blend and why combine them?

Each 10mg vial contains an equal-ratio combination of 5mg BPC-157 (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) and 5mg TB-500 (sequence: Ac-LKKTETQ). Researchers combine these two peptides because their mechanisms are thought to be complementary: BPC-157 acts via VEGFR2, nitric oxide, and FAK-paxillin pathway modulation; TB-500 acts primarily via actin-sequestering and cell migration promotion. By targeting different cellular pathways involved in tissue repair, the combination provides a broader research model than either compound alone. The blend format removes the need to prepare two separate vials, simplifying research protocols.

### How do I reconstitute the BPC-157 + TB-500 blend?

The blend reconstitutes identically to individual peptides. Draw 1–2mL of bacteriostatic water into a clean 31G syringe. Inject slowly down the inner glass wall of the vial. Gently swirl — do not shake or vortex — until the lyophilised powder is fully dissolved. The solution should be clear and colourless. With 1mL BAC water: each component is at 5mg/mL (BPC-157 5mg/mL + TB-500 5mg/mL). With 2mL: 2.5mg/mL each. Storage: Lyophilised at −20°C up to 24 months. Reconstituted at 2–8°C, use within 4 weeks, protected from light.

### Is the BPC-157 + TB-500 blend legal in Australia and what quality testing does it have?

Legal status: Both BPC-157 and TB-500 are legal to purchase in Australia for laboratory research purposes. Neither is a scheduled substance under the Poisons Standard when sold for research use only. Not for human consumption, therapeutic, cosmetic, or veterinary use. Quality: Batch PW-260311, verified at 99.0% HPLC purity for the combined blend. Both components are independently quality-tested before blending. The COA covers: HPLC purity for each component, mass spectrometry identity confirmation (BPC-157: MW 1419.53 Da; TB-500: MW 895.08 Da), and sterility screening. Full COA available in our COA Library.

### Should I buy the blend or separate BPC-157 and TB-500?

The blend is ideal when your research protocol uses both peptides at a 1:1 ratio — it simplifies preparation, reduces the number of vials to handle, and is more cost-effective than purchasing separately. If your research requires variable ratios of BPC-157 to TB-500 (e.g., 2:1, 1:2), or if you're studying each compound independently in separate assays, purchasing them separately gives more flexibility. We offer standalone BPC-157 10mg at /products/bpc-157 and the blend — choose based on your specific research design.

### What is TB-500 and how does it work?

TB-500 is a synthetic peptide fragment derived from thymosin beta-4 (Tβ4), a 43-amino acid protein. The active fragment commonly referred to as TB-500 has the sequence Ac-LKKTETQ (acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln). Thymosin beta-4's primary mechanism involves sequestering G-actin (globular actin monomers), which regulates actin polymerisation dynamics and thereby influences cell migration, wound healing, and tissue remodelling. In preclinical research, TB-500 has been studied for promotion of endothelial and keratinocyte migration, cardiac tissue repair models, anti-inflammatory effects in muscle and connective tissue models, and systemic distribution to multiple tissue types. Not for human consumption — for research use only.

### Why is the BPC-157 to TB-500 ratio 1:1 in this blend?

The 1:1 (5mg:5mg) ratio is the most widely used combination ratio in published preclinical literature and represents the standard starting point for dual-peptide tissue repair research. It provides equal molar availability of both compounds (accounting for their different molecular weights — BPC-157 at 1419.53 Da and TB-500 at 895.08 Da, so 5mg each represents different molar quantities). The 1:1 ratio by mass provides a practical, reproducible benchmark. Researchers requiring different ratios for mechanistic studies should purchase BPC-157 10mg at /products/bpc-157 and TB-500 separately to formulate custom ratios. Not for human consumption — for research use only.

### How does the blend compare to purchasing BPC-157 10mg separately?

Purchasing the blend vs. standalone BPC-157 10mg depends on your research design. The blend ($139.99) provides 5mg BPC-157 + 5mg TB-500 in a single vial — effectively two research compounds in one preparation at a lower combined cost than purchasing equivalent amounts separately. Standalone BPC-157 10mg ($89.99) at /products/bpc-157 gives you the full 10mg of BPC-157 alone, with no TB-500 — appropriate for research protocols requiring only BPC-157, higher BPC-157 doses, or independent compound analysis. Not for human consumption — for research use only.

### How do I confirm both peptides are present in the blend?

Both BPC-157 and TB-500 are independently confirmed in the Certificate of Analysis for Batch PW-260311 via: HPLC analysis showing separate retention time peaks for each component, confirming their individual presence and purity; and mass spectrometry confirming both molecular weights (BPC-157: 1419.53 Da; TB-500: 895.08 Da) in a single vial. The COA is publicly available in our COA Library. For researchers requiring additional identity verification, the reconstituted blend can be analysed independently using standard HPLC-MS with reference standards for each peptide. Not for human consumption — for research use only.

### Is the blend stable when reconstituted compared to individual peptides?

The blend's reconstituted stability is comparable to the individual peptides reconstituted separately. Both BPC-157 and TB-500 are stable in aqueous solution at 2–8°C for up to 4 weeks when reconstituted in bacteriostatic water. The presence of both peptides in the same solution does not produce known stability interactions — they are chemically distinct peptides that do not react with each other in solution. Standard handling applies: avoid freeze-thaw cycling of the reconstituted solution, protect from light, and label with reconstitution date. Not for human consumption — for research use only.

### What research literature supports combining BPC-157 and TB-500?

The rationale for combining BPC-157 and TB-500 is based on their complementary mechanisms identified in separate preclinical studies. BPC-157's documented effects via the NO/VEGFR2/FAK-paxillin pathways act at different cellular nodes than TB-500's actin-sequestering and cell migration-promoting activity. Published rodent studies on each compound individually in tendon, muscle, and wound healing models form the evidence base. While head-to-head combination studies in a single controlled model are limited in the published literature, the mechanistic complementarity and the breadth of individual compound data underpin the combination's use in complex tissue repair research protocols. Not for human consumption — for research use only.

## Compliance

Sold strictly for in-vitro laboratory and research purposes only. Not for human consumption, therapeutic use, or veterinary use. Purchasers must be 18 years of age or older. See https://www.auspeptidewarehouse.com.au/legal for full terms.